Originally published December 8 2005
Drug company Merck to cut jobs in major scaling back
by Mike Adams, the Health Ranger, NaturalNews Editor
By cutting jobs in the U.S., Merck, a pharmaceutical giant, will adjust its operations under the guidance of new CEO Richard Clark, who intends to shift the focus of disease research to a smaller number of drug applications.
The Wall Street Journal reported that the plan would be the first big move by Richard Clark, who took over as CEO in May and has been hinting that major changes were needed to turn the troubled drugmaker around.
The report comes as one of Merck's most important products, its cholesterol-lowering drug Zocor, faces losing most of its $5 billion in sales next year when its patent expires.
Merck (Research), hurt by the withdrawal of the painkiller Vioxx last year and what analysts call weakness in its drug pipeline, has seen its stock slide nearly 70 percent over the past five years.
The report also comes as Merck gets set to return to Texas next week to defend itself in a third trial over its withdrawn painkiller, Vioxx.
Merck lost its first case in a state court in Texas in August but won its second case in its home state of New Jersey.
Estimates that Merck will shed up to several thousand jobs was "a good number to work with," the Journal report quoted one person familiar with the situation as saying.
The plan, which could be announced as early as Monday, includes cuts in operations in the U.S. and abroad as well as tighter focus on certain disease-research areas, the report added.
"We are carefully considering a variety of options to help improve our core business fundamentals" and will provide details by year-end, the report quoted a Merck spokeswoman as saying in a statement.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml